CIK 0001574094 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
RenovoRx, Inc.
Sign in to watch- Ticker
- RNXT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271448452
- Phone
- 408-800-2649
- Business address
- 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-15 | Agah Ramtin Chief Medical Officer | Purchase | +15,000 | $0.90 | $14K | 1,113,460 |
| 2025-04-15 | Bagai Shaun Chief Executive Officer | Purchase | +7,500 | $0.91 | $7K | 320,040 |
| 2025-04-14 | Kocak Ron VP, Controller and PAO | Grant or award · Stock Option | +166,400 | 166,400 | ||
| 2025-04-14 | Gentry Leesa Chief Clinical Officer | Grant or award · Stock Option | +26,477 | 26,477 | ||
| 2025-04-14 | Bagai Shaun Chief Executive Officer | Grant or award · Stock Option | +409,992 | 409,992 | ||
| 2025-04-14 | Agah Ramtin Chief Medical Officer | Grant or award · Stock Option | +254,542 | 254,542 | ||
| 2025-04-11 | Agah Ramtin Chief Medical Officer | Purchase | +20,000 | $0.80 | $16K | 1,098,460 |
| 2025-04-10 | Kocak Ron VP Controller and PAO | Purchase | +6,500 | $0.79 | $5K | 12,595 |
| 2025-04-09 | Kocak Ron VP Controller and PAO | Purchase | +6,000 | $0.80 | $5K | 6,095 |
| 2025-04-09 | Agah Ramtin Chief Medical Officer | Purchase | +30,000 | $0.81 | $24K | 1,078,460 |
| 2025-04-09 | Bagai Shaun Chief Executive Officer | Purchase | +10,000 | $0.83 | $8K | 312,540 |
| 2025-04-08 | Kocak Ron VP Controller and PAO | Purchase | +95 | $0.80 | $76 | 95 |
| 2025-04-08 | Marton Laurence Director | Purchase | +12,050 | $0.85 | $10K | 45,684 |
| 2025-04-08 | Agah Ramtin Chief Medical Officer | Purchase | +26,000 | $0.84 | $22K | 1,048,460 |
| 2025-04-07 | Bagai Shaun Chief Executive Officer | Purchase | +10,000 | $0.83 | $8K | 302,540 |
| 2024-10-01 | Marton Laurence Director | Grant or award · Stock Options (right to buy) | +25,099 | 25,099 | ||
| 2024-10-01 | Spiegel Robert J. Director | Grant or award · Stock Options (right to buy) | +25,099 | 25,099 | ||
| 2024-10-01 | RYAN UNA S Director | Grant or award · Stock Options (right to buy) | +25,099 | 25,099 | ||
| 2024-10-01 | Macfarlane K. Angela Director | Grant or award · Stock Options (right to buy) | +25,099 | 25,099 | ||
| 2024-03-06 | Gentry Leesa Chief Clinical Officer | Grant or award · Options | +190,000 | 190,000 |
Page 3 of 6 · 120 trades